ロード中...
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
OBJECTIVES: To determine the predictive factors of clinical response to infliximab in patients with refractory psoriatic polyarthritis. METHODS: A multicentre open study which included 69 patients with psoriatic polyarthritis refractory to methotrexate (15 mg/week at least for 8 weeks). Patients wer...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1856049/ https://ncbi.nlm.nih.gov/pubmed/17179176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.060079 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|